title: Antipsychotic polypharmacy: do benefits justify the risks?
authors.forename: Andre M
authors.initials: AM
authors.lastname: Tapp
authors.forename: Amanda Ernst
authors.initials: AE
authors.lastname: Wood
authors.forename: Nael
authors.initials: N
authors.lastname: Kilzieh
authors.forename: Annette
authors.initials: A
authors.lastname: Kennedy
authors.forename: Murray A
authors.initials: MA
authors.lastname: Raskind
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy*; D012189:Retrospective Studies; D012306:Risk; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents